Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
JAMA Oncology
|
September 23, 2021
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial
Andrew X Zhu, Teresa Macarulla, Milind M Javle, et al.
Journal of the National Cancer Institute
|
April 11, 2023
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma
Kristen Spencer, Leontios Pappas, Islam Baiev, et al.
JCO Precision Oncology
|
August 10, 2023
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
Leontios Pappas, Islam Baiev, Stephanie Reyes, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 26, 2016
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience
Jordan M Cloyd, Matthew H G Katz, Laura Prakash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2018
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma
Eugene J Koay, Yeonju Lee, Vittorio Cristini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations
James J Harding, Do-Youn Oh, Teresa Macarulla Mercade, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
JAMA Oncology
|
September 23, 2021
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial
Andrew X Zhu, Teresa Macarulla, Milind M Javle, et al.
Journal of the National Cancer Institute
|
April 11, 2023
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma
Kristen Spencer, Leontios Pappas, Islam Baiev, et al.
JCO Precision Oncology
|
August 10, 2023
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
Leontios Pappas, Islam Baiev, Stephanie Reyes, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 26, 2016
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience
Jordan M Cloyd, Matthew H G Katz, Laura Prakash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2018
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma
Eugene J Koay, Yeonju Lee, Vittorio Cristini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations
James J Harding, Do-Youn Oh, Teresa Macarulla Mercade, et al.
Page
of 8